When good cholesterol turns bad: the evolving saga of CETP inhibitors and clinical strategies to elevate high-density lipoprotein.
Oram
John F
JF
Department of Medicine, Box 356426, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195-6426, USA. joram@u.washington.edu
Heinecke
Jay W
JW
D064286:ATP Binding Cassette Transporter 1; D018528:ATP-Binding Cassette Transporters / Q000235:genetics; D000924:Anticholesteremic Agents / Q000494:pharmacology / Q000627:therapeutic use; D050197:Atherosclerosis / Q000097:blood / Q000517:prevention & control; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000097:blood* / Q000235:genetics; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors*; D008076:Cholesterol, HDL / Q000097:blood* / Q000187:drug effects*; D008078:Cholesterol, LDL / Q000097:blood*; D006801:Humans; D008099:Liver / Q000378:metabolism; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use
D064286:ATP Binding Cassette Transporter 1; D018528:ATP-Binding Cassette Transporters; D000924:Anticholesteremic Agents; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D011804:Quinolines; C483909:torcetrapib